Reynoso BMF, Flores VG, Gallardo LMJ, Navarro OE, Magos VFJ, Díaz MDA, Padilla RN

Language: Spanish
References: 16
Page: 3-10
PDF size: 185.63 Kb.

ABSTRACT

Introduction: Since the report of cases of pneumonia of unknown origin in Wuhan, China in 2019, the SARS-CoV-2 virus has spread to practically the whole world, affecting different social groups. It was highlighted that young people and women are less clinically affected by this condition. Objective: To analyze the frequency and lethality of COVID-19 in women under 19 years of age in Mexico. Material and methods: A quantitative, cross-sectional, analytical, retrolective study was designed, based on the open data set of the National Epidemiological Surveillance System until March 31, 2021. The study universe was the records of female persons under 19 years of age cataloged as suspects of COVID-19. Statistical analysis was descriptive for all variables. To contrast statistical hypotheses, the χ² test was used, and the Z test of proportions for categorical variables. To measure the effect of different variables on case fatality, the Odds Ratio was used, reporting them with 95% confidence intervals. A logistic regression model was generated to identify whether age had a confounding effect. Results: Of the women under 19 years of age suspected of COVID-19 (165,860), 48,091 tested positive for SARS-CoV-2. Women between 15 and 18 years old predominated. Regarding deaths, deaths in children under two years of age predominated. Most of the people who died were hospitalized and developed pneumonia. Conclusion: As in the general population, comorbidities were shown to influence death from COVID-19. Those under two years of age predominated in terms of deaths.

REFERENCES

1. World Health Organization. Pneumonia of unknown cause-China. January 5, 2020. Ginebra. 2020. Available in: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/

2. Hong H, Wang Y, Chung HT, Chen CJ. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatri Neonatol. 2020; 61 (2): 131-132. doi: https://doi.org/10.1016/j.pedneo.2020.03.001.

3. Padilla-Raygoza N, Sandoval-Salazar C, Diaz-Becerril LA, Beltran-Campos V, Diaz-Martinez DA, Navarro-Olivos et al. Update of the evolution of SARS-CoV-2 infection, COVID-19, and mortality in Mexico until May 15, 2020: an ecological study. International Journal of TROPICAL DISEASE & Health. 2020; 41 (5): 36-45. doi: https://doi.org/10.9734/IJTDH/2020/v41i/530277.

4. Padilla-Raygoza N, Sandoval-Salazar C, Ramírez-Gómez XS, Díaz-Becerril LA, Navarro-Olivos E, Gallardo-Luna MJ et al. Status of disease by novel coronavirus and analysis of mortality in Mexico, until July 31, 2020. Journal of Medicine and Health Research. 2020; 5 (1): 26-35. Available in: https://www.ikprress.org/index.php/JOMAHR/article/view/5483

5. Centers Disease Control and Prevention. COVID-19 in children and teens. Atlanta. 2021. Available in: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children/symptoms.html

6. Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 10.1136/archdischild-2020-320338. doi: https://doi.org/10.1136/archdischild-2020-320338.

7. Cousins S. COVID-19 has "devastating" effect on women and girls. Lancet. 2020; 396 (10247): 301-302. doi: https://doi.org/10.1016/S0140-6736(20)31679-2

8. Dirección General de Epidemiología. Secretaría de Salud. Bases de datos abiertos históricos 2021. 31 de marzo 2021. Ciudad de México, 2021. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/634704/Datos_abiertos_historicos_2021.pdf

9. World Health Organization. Young people's health – a challenge for society report of a study group on young people and health for all by the year 2000, technical report series, No 731. Geneva: World Health Organization; 2003. Available in: http://whqlibdoc.who.int/trs/WHO_TRS_731.pdf

10. Dirección General de Epidemiología. Secretaría de Salud. Comunicado Oficial. Actualización de la definición operacional de caso sospechoso de enfermedad respiratoria viral. Ciudad de México, 24 Agosto 2020. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/573732/Comunicado_Oficial_DOC_sospechoso_ERV_240820.pdf

11. Subsecretaria de Prevención y Promoción de la Salud. Secretaría de Salud. Informe técnico diario COVID-19 31 marzo 2021. Ciudad de México, 2021. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/626491/Comunicado_Tecnico_Diario_COVID-19_2021.03.31.pdf

12. World Health Organization. Estimating mortality from COVID-19. Geneve, 2020. Available in: https://www.who.int/newsroom/commentaries/detail/estimating-mortality-from-covid-19

13. Padilla-Raygoza N, Sandoval Salazar C, Ramírez-Gómez XS, Navarro-Olivos E, Gallardo-Luna MJ, Magos-Vazquez FJ et al. Status of Novel Coronavirus disease and analysis of mortality in Mexico, until June 30th, 2020: an ecological study. Biomed Pharmacol J. 2020; 13 (4): 1781-1790. doi: https://dx.doi.org/10.13005/bpj/2053.

14. Patel, NA. Pediatric COVID-19: Systematic review of the literature. American Journal of Otolaryngology. 2020; 41 (5): 102573. doi: https://doi.org/10.1016/j.amjoto.2020.102573.

15. Camara E, Barry IK, Diallo FB, Diallo ML, Diop MM, Cherif MS et al. Profil épidémiologique et clinique des enfants atteins de la maladie á coronavirus (COVID-19) au Centre de Traitement des Epidémies et Prévention des infections (CTEPI) du CHU de Donka á Conakry. Pan Afr Med J. 2020; 37 (363). doi: https://doi.org.com/10.11604/pamj.2020.37.363./full.

16. Mangia C, Russo A, Civitelli S, Luca Giancolo EA. Differenze sesso/genere nella letalitá COVID-19: cosa dicono e non dicono i dati. E&P. 2020; 44 (S2): 400-406. doi: https://doi.org/10.19191/EP20.5-6.S2.145.